These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9450175)

  • 1. Drug delivery to the lymphatic system.
    Porter CJ
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):333-93. PubMed ID: 9450175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic transport of orally administered drugs.
    Reddy LH; Murthy RS
    Indian J Exp Biol; 2002 Oct; 40(10):1097-109. PubMed ID: 12693689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the lymphatics using dendritic polymers (dendrimers).
    Kaminskas LM; Porter CJ
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):890-900. PubMed ID: 21683746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal lymphatic transport for drug delivery.
    Yáñez JA; Wang SW; Knemeyer IW; Wirth MA; Alton KB
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):923-42. PubMed ID: 21689702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.
    Lee JB; Zgair A; Malec J; Kim TH; Kim MG; Ali J; Qin C; Feng W; Chiang M; Gao X; Voronin G; Garces AE; Lau CL; Chan TH; Hume A; McIntosh TM; Soukarieh F; Al-Hayali M; Cipolla E; Collins HM; Heery DM; Shin BS; Yoo SD; Kagan L; Stocks MJ; Bradshaw TD; Fischer PM; Gershkovich P
    J Control Release; 2018 Sep; 286():10-19. PubMed ID: 30016732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres.
    Yanagawa A; Iwayama T; Saotome T; Shoji Y; Takano K; Oka H; Nakagawa T; Mizushima Y
    J Microencapsul; 1989; 6(2):161-4. PubMed ID: 2723958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
    Trevaskis NL; Kaminskas LM; Porter CJ
    Nat Rev Drug Discov; 2015 Nov; 14(11):781-803. PubMed ID: 26471369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs: comparison between anesthetized and freely moving conscious rat models.
    Dahan A; Mendelman A; Amsili S; Ezov N; Hoffman A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):367-74. PubMed ID: 17980560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV.
    Lalanne M; Paci A; Andrieux K; Dereuddre-Bosquet N; Clayette P; Deroussent A; Ré M; Vassal G; Couvreur P; Desmaële D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2237-40. PubMed ID: 17276686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.
    Hu L; Quach T; Han S; Lim SF; Yadav P; Senyschyn D; Trevaskis NL; Simpson JS; Porter CJ
    Angew Chem Int Ed Engl; 2016 Oct; 55(44):13700-13705. PubMed ID: 27482655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic delivery of niosome encapsulated methotrexate.
    Jain CP; Vyas SP
    Pharmazie; 1995 May; 50(5):367-8. PubMed ID: 7604072
    [No Abstract]   [Full Text] [Related]  

  • 16. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New molecular markers for the study of tumour lymphangiogenesis.
    Jackson DG
    Anticancer Res; 2001; 21(6B):4279-83. PubMed ID: 11908682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions.
    Reddiar SB; Xie Y; Abdallah M; Han S; Hu L; Feeney OM; Gracia G; Anshabo A; Lu Z; Farooq MA; Styles IK; Phillips ARJ; Windsor JA; Porter CJH; Cao E; Trevaskis NL
    Pharmacol Rev; 2024 Oct; 76(6):1326-1398. PubMed ID: 39179383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.